Janney Montgomery Scott’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $212K | Sell |
|
|||||
|
2025
Q2 | $347K | Sell |
|
|||||
|
2025
Q1 | $380K | Sell |
|
|||||
|
2024
Q4 | $415K | Sell |
|
|||||
|
2024
Q3 | $445K | Sell |
|
|||||
|
2024
Q2 | $407K | Buy |
|
|||||
|
2024
Q1 | $117K | Buy |
|
|||||
|
2023
Q4 | $132K | Sell |
|
|||||
|
2023
Q3 | $195K | Buy |
|
|||||
|
2023
Q2 | $189K | Buy |
|
|||||
|
2023
Q1 | $180K | Buy |
|
|||||
|
2022
Q4 | $243K | Hold |
|
|||||
|
2022
Q3 | $267K | Hold |
|
|||||
|
2022
Q2 | $221K | Sell |
|
|||||
|
2022
Q1 | $409K | Hold |
|
|||||
|
2021
Q4 | $349K | Sell |
|
|||||
|
2021
Q3 | $397K | Buy |
|
|||||
|
2021
Q2 | $406K | Buy |
|
|||||
|
2021
Q1 | $256K | Sell |
|
|||||
|
2020
Q4 | $218K | Buy |
|
|||||
|
2020
Q3 | $98K | Buy |
|
|||||
|
2020
Q2 | $122K | Buy |
|
|||||
|
2020
Q1 | $45K | Sell |
|
|||||
|
2019
Q4 | $78K | Sell |
|
|||||
|
2019
Q3 | $74K | Hold |
|
|||||
|
2019
Q2 | $98K | Sell |
|
|||||
|
2019
Q1 | $218K | Sell |
|
|||||
|
2018
Q4 | $219K | Sell |
|
|||||
|
2018
Q3 | $224K | Hold |
|
|||||
|
2018
Q2 | $168K | Buy |
|
|||||
|
2018
Q1 | $138K | Sell |
|
|||||
|
2017
Q4 | $151K | Sell |
|
|||||
|
2017
Q3 | $164K | Sell |
|
|||||
|
2017
Q2 | $185K | Buy |
|
|||||
|
2017
Q1 | $267K | Hold |
|
|||||
|
2016
Q4 | $202K | Sell |
|
|||||
|
2016
Q3 | $146K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $73K | Sell |
|
|||||
|
2015
Q4 | $268K | Buy |
|
|||||
|
2015
Q3 | $216K | Buy |
|
|||||
|
2015
Q2 | $256K | Buy |
|
|||||
|
2015
Q1 | $121K | Buy |
|
|||||
|
2014
Q4 | $159K | Hold |
|
|||||
|
2014
Q3 | $128K | Hold |
|
|||||
|
2014
Q2 | $166K | Hold |
|
|||||
|
2014
Q1 | $138K | Buy |
|
|||||
|
2013
Q4 | $85.5K | Buy |
|